Solar Foods receives positive EFSA safety opinion for Solein protein

• Solar Foods received a positive EFSA safety opinion for its Solein protein on November 9, 2026, advancing its EU market authorization process.
• EU authorization is expected within 7–9 months; Solar Foods shares rose more than 10% on November 9.
• The opinion reduces regulatory risk, enabling progress on binding sales contracts, financing and preparations for the Factory 02 investment decision.
• Allergy vaccine developer Desentum raised EUR 28 million, according to an October 12 update.
• Basemark participated in a Patria-Telia demonstration remotely controlling an armored vehicle in Finland from Tokyo, highlighted in an October 2 update.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Springvest Oyj published the original content used to generate this news brief on November 10, 2026, and is solely responsible for the information contained therein.